<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00096681</url>
  </required_header>
  <id_info>
    <org_study_id>CIPRA-SA Project 3A</org_study_id>
    <secondary_id>U19AI053217</secondary_id>
    <secondary_id>CIPRA</secondary_id>
    <secondary_id>Project 3A</secondary_id>
    <nct_id>NCT00096681</nct_id>
  </id_info>
  <brief_title>Prevalence of HIV and Tuberculosis in Masiphumelele Township, Cape Town, South Africa</brief_title>
  <official_title>Protocol for Cross-Sectional Survey of Acid-Fast Bacilli (AFB) Smear Positive and/or Culture Positive Tuberculosis in the Masiphumelele Township</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CIPRA SA</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>CIPRA SA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to estimate the amount of HIV and tuberculosis (TB) infection in
      individuals 15 years and older in the Masiphumelele township of Cape Town, South Africa. Data
      collected in this study will be used to predict the effect of introducing anti-HIV therapy in
      this community.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      TB is the most common opportunistic infection among HIV infected people, and is the most
      common cause of death in HIV infected people in Africa. The Masiphumelele township of Cape
      Town, South Africa, with its high rates of TB and HIV, is representative of many poor
      communities of Africa. Via random sampling, this study will assess the prevalence of HIV and
      TB infections in the Masiphumelele township. Knowledge gained from this study will be used to
      predict if introducing antiretroviral therapy will reduce the prevalence of TB in this
      community.

      Selection and enrollment of participants will last about 4 months. Potential participants
      will be visited in their homes by fieldworkers, who will explain the study. Participants will
      be invited to either go to the clinic on the day of the fieldworker's visit or to go on a
      different day. Participants who go to the clinic on the day of the visit will have two sputum
      samples collected with a nebulizer. Participants who do not go to the clinic on the visit day
      will be given a sputum sample bottle and will be asked to collect a sputum sample in the
      early morning the day before their clinic appointment. At the clinic appointment, another
      sputum sample will be collected from these participants. Direct smear acid-fast bacilli and
      Mycobacterium tuberculosis cultures will be done on both sputum samples. Participants who
      test positive for TB will be referred for TB treatment at the clinic. Participants will also
      be asked to complete a study questionnaire and will undergo an anonymous oral HIV test at the
      clinic visit.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2005</start_date>
  <completion_date type="Actual">February 2006</completion_date>
  <primary_completion_date type="Actual">August 2005</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Microbiologically Confirmed Pulmonary Tuberculosis</measure>
    <time_frame>Pulmonary Tuberculosis diagnosed from sputum sample obtained at the study visit</time_frame>
    <description>Confirmed Pulmonary Tuberculosis based on the sputum smear and culture results. The sputum sample was obtained at the once off study visit.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With a Positive HIV Test</measure>
    <time_frame>HIV status at the time of the study visit</time_frame>
    <description>Prevalence of HIV in the community based on a positive oral mucosal transudate sample obtained at the once off study visit.</description>
  </secondary_outcome>
  <enrollment type="Actual">762</enrollment>
  <condition>HIV Infections</condition>
  <condition>Tuberculosis</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Sputum samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Residents of the Masiphumelele township of Cape Town, South Africa
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Resident of the Masiphumelele township for at least 1 week prior to study entry

          -  Willing to provide informed consent

          -  Willing to comply with study requirements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Linda Gail Bekker, MBChB, FCP, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Medicine, University of Cape Town</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James McIntyre, MBChB, MRCOG</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of the Witwatersrand and Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital</affiliation>
  </overall_official>
  <reference>
    <citation>Aaron L, Saadoun D, Calatroni I, Launay O, MÃ©main N, Vincent V, Marchal G, Dupont B, Bouchaud O, Valeyre D, Lortholary O. Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect. 2004 May;10(5):388-98. Review.</citation>
    <PMID>15113314</PMID>
  </reference>
  <reference>
    <citation>Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet. 2002 Jun 15;359(9323):2059-64.</citation>
    <PMID>12086758</PMID>
  </reference>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 12, 2004</study_first_submitted>
  <study_first_submitted_qc>November 12, 2004</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2004</study_first_posted>
  <results_first_submitted>January 14, 2011</results_first_submitted>
  <results_first_submitted_qc>January 21, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 17, 2011</results_first_posted>
  <last_update_submitted>February 17, 2011</last_update_submitted>
  <last_update_submitted_qc>February 17, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 14, 2011</last_update_posted>
  <responsible_party>
    <name_title>James McIntyre</name_title>
    <organization>CIPRA SA</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Participants From the Community</title>
          <description>The number of participants from the community who attended the clinic for a once off study visit</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="762"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="762"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Participants From the Community</title>
          <description>The number of participants from the community who attended the clinic for a once off study visit</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="762"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="726"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30" spread="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="422"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="340"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>South Africa</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="762"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Microbiologically Confirmed Pulmonary Tuberculosis</title>
        <description>Confirmed Pulmonary Tuberculosis based on the sputum smear and culture results. The sputum sample was obtained at the once off study visit.</description>
        <time_frame>Pulmonary Tuberculosis diagnosed from sputum sample obtained at the study visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Participants From the Community</title>
            <description>The number of participants from the community who attended the clinic for a once off study visit</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Microbiologically Confirmed Pulmonary Tuberculosis</title>
          <description>Confirmed Pulmonary Tuberculosis based on the sputum smear and culture results. The sputum sample was obtained at the once off study visit.</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="762"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With a Positive HIV Test</title>
        <description>Prevalence of HIV in the community based on a positive oral mucosal transudate sample obtained at the once off study visit.</description>
        <time_frame>HIV status at the time of the study visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Participants From the Community</title>
            <description>The number of participants from the community who attended the clinic for a once off study visit</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With a Positive HIV Test</title>
          <description>Prevalence of HIV in the community based on a positive oral mucosal transudate sample obtained at the once off study visit.</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="762"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="174"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Participants From the Community</title>
          <description>The number of participants from the community who attended the clinic for a once off study visit</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="762"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="762"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof LG Bekker</name_or_title>
      <organization>Desmond Tutu HIV Centre</organization>
      <phone>+2721 633 6599 ext 21</phone>
      <email>Linda-Gail.Bekker@hiv-research.org.za</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

